Carcinoembryonic Antigen-Related Cell Adhesion Molecule 19 (CEACAM19) (Middle Region) Peptide
-
- Target See all CEACAM19 products
- CEACAM19 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 19 (CEACAM19))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CEACAM19 antibody (Catalog #: ARP49488_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CEACAM19 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 19 (CEACAM19))
- Synonyms
- CEAL1 Peptide, C130022P09Rik Peptide, carcinoembryonic antigen related cell adhesion molecule 19 Peptide, carcinoembryonic antigen-related cell adhesion molecule 19 Peptide, CEACAM19 Peptide, Ceacam19 Peptide
- Background
-
The specific function of the protein remains unknown.
Alias Symbols: CEAL1, MGC105097
Protein Size: 300 - Molecular Weight
- 33 kDa
- Gene ID
- 56971
- NCBI Accession
- NM_020219, NP_064604
- UniProt
- Q7Z692
-